Effect of 3,4-diaminopyridine on rat extensor digitorum longus muscle paralyzed by local injection of botulinum neurotoxin

Toxicon

Volumn 34, Issue 2, 1996, Pages 237-249

  Adler, Michael ^a   Macdonald, Douglas A ^b   Sellin, Lawrence C ^b,c   Parker, Gerald W ^b  

^a US ARMY MEDICAL RESEARCH INSTITUTE OF CHEMICAL DEFENSE   (United States)

^b UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^c UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DIAMINOPYRIDINE; BOTULINUM TOXIN; PYRIDOSTIGMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXTENSOR DIGITORUM LONGUS MUSCLE; INTRAVENOUS DRUG ADMINISTRATION; MALE; MUSCLE TWITCH; NONHUMAN; PARALYSIS; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0030027138     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/0041-0101(95)00127-1     Document Type: Article

References (39)

1. Adler, M., Deshpande, S. S., Foster, R. E., Maxwell, D. M. and Albuquerque, E. X. (1992) Effects of subacute pyridostigmine administration on mammalian skeletal muscle function. J. appl. Toxicol. 12, 25-33.
2. Adler, M., Deshpande, S. S., Sheridan, R. E. and Lebeda, F. J. (1994) Evaluation of captopril and other potential therapeutic compounds in antagonizing botulinum toxin-induced muscle paralysis. In: Therapy with Botulinum Toxin, pp. 63-70 (Jankovic, J. and Hallett, M., Eds). New York: Marcel Dekker, Inc.
3. Adler, M., Scovill, J., Parker, G., Lebeda, F. J., Piotrowski, J. and Deshpande, S. S. (1995) Antagonism of botulinum toxin-induced muscle weakness by 3,4-diaminopyridine in rat phrenic nerve-hemidiaphragm preparations. Toxicon 33, 527-537.
4. Ball, A. P., Hopkinson, R. B., Farrell, I. D., Hutchison, J. G. P., Paul, R., Watson, R. D. S., Page, A. J. F., Parker, R. G. F., Edwards, C. W., Snow, M., Scott, D. K., Leone-Ganado, A., Hastings, A., Ghosh, A. C. and Gilbert, R. J. (1979) Human botulism caused by Clostridium botulimin type E: the Birmingham outbreak. Q. J. Med., New Series XLVIII, 191, 473-491.
5. Benett, M. K. and Scheller, R. H. (1993) The molecular machinery for secretion is conserved from yeast to neurons. Proc. natn. Acad. Sci. U.S.A. 90, 2559-2563.
6. Bever, C. T., Leslie, J., Camenga, D. L., Panitch, H. S. and Johnson, K. P. (1990) Preliminary trial of 3,4-diaminopyridine in patients with multiple sclerosis. Ann. Neurol. 21, 421-427.
7. Binz, T., Blasi, J., Yamasaki, S., Baumeister, A., Link, E., Sudhof, T. C., Jahn, R. and Niemann, H. (1994) Proteolysis of SNAP-25 by types E and A botulinal neurotoxins. J. biol. Chem. 269, 1617-1620.
8. Blasi, J., Chapman, E. R., Link, E., Binz, T., Yamasaki, S., De Camilli, P., Sudhof, T. C., Niemann, H. and Jahn, R. (1993) Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25. Nature 365, 160-163.
9. Burgen, A. S. V., Dickens, F. and Zatman, L. J. (1949) The action of botulinum toxin on the neuromuscular junction. J. Physiol., Lond. 134, 264-277.
10. Carpenter, F. G. (1967) Motor responses of the urinary bladder and skeletal muscle in botulinum intoxicated rats. J. Physiol, Lond. 188, 1-11.
11. Cornella, J.-X., Molgo, J. and Faille, L. (1993) Sprouting of mammalian motor nerve terminals induced by in vivo injection of botulinum type-D toxin and the functional recovery of paralysed neuromuscular junctions. Neurosci. Lett. 153, 61-64.
12. DePaiva, A., Ashton, A. C., Foran, P., Schiavo, G., Montecucco, C. and Dolly, J. O. (1993) Botulinum A like type B and tetanus toxins fulfils criteria for being a zinc-dependent protease. J. Neurochem. 61, 2338-2341.
13. Deshpande, S. S., Sheridan, R. E. and Adler, M. (1995) A study of zinc-dependent metalloendopeptidase inhibitors as pharmacological antagonists in botulinum neurotoxin poisoning. Toxicon 33, 551-557.
14. Dolly, J. O., Ashton, A. C, McInnes, C., Wadsworth, J. D. F., Poulain, B., Taue, L., Shone, C. C. and Melling, J. (1990) Clues to the multi-phasic inhibitory action of botulinum neurotoxins on release of transmitters. J. Physiol., Paris 84, 237-246.
15. Donadio, J. A., Gangarosa, E. J. and Faich, G. A. (1971) Diagnosis and treatment of botulism. J. infect. Dis. 124, 108-112.
16. Fujii, N., Kimura, K., Yokosawa, N., Tsuzuki, K. and Oguma, K. (1992) A zinc-protease specific domain in botulinum and tetanus neurotoxins. Toxicon 30, 1486-1488.
17. Huttner, W. B. (1993) Snappy exocytoxins. Nature 365, 104-105.
18. Jongeneel, C. V., Bouvier, J. and Bairoch, A. (1989) A unique signature identifies a family of zinc-dependent metallopeptidases. FEBS Lett. 242, 211-214.
19. Katz, B. and Miledi, R. (1979) Estimates of quantal content during chemical potentiation of transmitter release. Proc. R. Soc. B. 205, 369-378.
20. Kauffman, J. A., Way, Jr, J. F., Siegel, S. and Sellin, L. C. (1985) Comparison of the action of types A and F botulinum toxin at the rat neuromuscular junction. Toxicol. appl. Pharmac. 79, 211-217.
21. Link, E., Lambert, E., Chjou, J. H., Binz, T., Yamasaki, S., Eisel, U., Baumert, M., Sudhof, T. C., Niemann, H. and Jahn, R. (1992) Tetanus toxin action: inhibition of neurotransmitter release linked to synaptobrevin proteolysis. Biochem. biophys. Res. Commun. 189, 1017-1023.
22. MacDonald, K. L., Spengler, R. F., Hatheway, C. L., Hargrett, N. T. and Cohen, M. L. (1985) Type A botulism from sauteed onions. JAMA 253, 1275-1278.
23. McEvoy, K. M., Windebank, A. J., Jasper, R. D. and Low, P. A. (1989) 3,4-Diaminopyridine in the treatment of Lambert-Eaton myasthenic syndrome. N. Engl. J. Med. 321, 1567-1571.
24. Molgo, J., DasGupta, B. R. and Thesleff, S. (1989) Characterization of the actions of botulinum neurotoxin type E at the rat neuromuscular junction. Acta physiol. scand. 137, 497-501.
25. Molgo, J., Lundh, H. and Thesleff, S. (1980) Potency of 3,4-diaminopyridine and 4-aminopyridine on mammalian neuromuscular transmission and the effects of pH changes. Eur. J. Pharmac. 61, 25-34.
26. Oyler, G. A., Higgins, G. A., Hart, R. A., Battenberg, E., Billingsley, M., Bloom, F. E. and Wilson, M. C. (1989) The identification of a novel synaptosomal-associated protein SNAP-25, differentially expressed by neural subpopulations. J. Cell Biol. 109, 3039-3052.
27. Pickett, J. B. (1988) AAEE case report # 16: botulism. Muscle Nerve 11, 1201-1205.
28. Powers, J. C. and Harper, J. W. (1986) Inhibitors of metalloproteases. In: Proteinase Inhibitors, pp. 219-298 (Barrett, A. J. and Salvesen, G. Eds). Amsterdam: Elsevier Science Publishers BV.
29. Schiavo, G., Bonfenati, F., Poulain, B., Rossetto, O., De Laureto, P. P., DasGupta, B. R. and Montecucco, C. (1992) Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature 359, 832-835.
30. Schiavo, G., Santucci, A., DasGupta, B. R., Mehta, P. P., Jontes, J., Benfenati, F., Wilson, M. C. and Montecucco, C. (1993a) Botulinum neurotoxins serotypes A and E cleave SNAP-25 at distinct COOH-terminal peptide bonds. FEBS Lett. 335, 99-103.
31. Schiavo, G., Shone, C., Rossetto, O., Frances, C., Alexander, G. and Montecucco, C. (1993b) Botulinum neurotoxin serotype F is a zinc endopeptidase specific for VAMP/synaptobrevin. J. biol. Chem. 268, 11,516-11,519.
32. Sellin, L. C., Kauffman, J. A. and DasGupta, B. R. (1983a) Comparison of the effects of botulinum neurotoxin types A and E at the rat neuromuscular junction. Med. Biol. 61, 120-125.
33. Sellin, L. C., Thesleff, S. and DasGupta, B. R. (1983b) Different effects of types A and B botulinum toxin on transmitter release at the rat neuromuscular junction. Acta physiol. scand. 199, 127-133.
34. Sheridan, R. E. and Deshpande, S. S. (1995) Interactions between heavy metal chelators and botulinum neurotoxin at the neuromuscular junction. Toxicon 33, 539-549.
35. Siegel, L. S., Johnson-Winegar, A. D. and Sellin, L. C. (1986) Effect of 3,4-diaminopyridine on the survival of mice injected with botulinum neurotoxin type A, B, E or F. Toxicol. appl. Pharmac. 84, 255-263.
36. Simpson, L. L. (1986a) Molecular pharmacology of botulinum toxin and tetanus toxin. A. Rev. Pharmac. Toxicol. 26, 427-453.
37. Simpson L. L. (1986b) A preclinical evaluation of ammopyridines as putative therapeutic agents in the treatment of botulism. Infect. Immun. 52, 858-862.
38. Simpson, L. L., Coffield, J. A. and Bakry, N. (1993) Chelation of zinc antagonizes the neuromuscular blocking properties of the seven serotypes of botulinum neurotoxin as well as tetanus toxin. J. Pharmac. exp. Ther. 267, 720-727.
39. 82 bond of rat synaptobrevin-2. Biochem. biophys. Res. Commun. 200, 829-835.